Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: The Effect of Farlong® NotoGinseng™ (Ginseng Plus®) on Cholesterol and Blood Pressure [Phase 2]
Phase 2 trial evaluating Farlong NotoGinseng (Ginseng Plus) for effects on cholesterol and blood pressure has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Effect of Oral Caffeine and L-Citrulline Supplementation on Arterial Function in Healthy Males [NA]
Clinical trial evaluating the effect of oral caffeine and L-citrulline supplementation on arterial function in healthy adults, completed wit…
-
FDA approval · 2020-12-28FDA Approved: AMLODIPINE BESYLATE AND OLMESARTRAN MEDOXOMIL — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved a supplemental application to allow Alembic Pharmaceuticals to market a generic fixed-dose combination of amlodipine besyla…
-
FDA approval · 2020-12-28FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a fixed-dose combination product of amlodipine and olmesartan medoxomil from Aurobindo Pharma Li…
-
FDA approval · 2020-12-28FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Micro Labs Limited)
The FDA approved a supplemental application for AMLODIPINE AND OLMESARTAN MEDOXOMIL from Micro Labs Limited, enabling its marketing as a fix…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-28Clinical Trial Update: Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension [Phase 4]
Phase 4 trial updating on dapagliflozin's effects on blood pressure variability and ambulatory arterial stiffness in hypertension.
-
FDA approval · 2020-12-22FDA Approved: FUROSEMIDE — Supplemental Application (Marlex Pharmaceuticals, Inc.)
The FDA approved a supplemental application for furosemide from Marlex Pharmaceuticals, Inc., indicating an additional/or updated approval f…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children. [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of eplerenone for treating hypertension in children has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: The Long-term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years [Phase 3]
Long-term Phase 3 trial evaluating the safety of eplerenone for hypertension in children aged 6 to 16 has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Achieving Blood Pressure Control Through Enhanced Discharge [NA]
A completed clinical trial evaluating strategies to improve blood pressure control after discharge in hypertension patients, with results po…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: 24-hour Blood Pressure Measurements and Ischemic Conditioning [NA]
A completed clinical trial evaluating 24-hour blood pressure measurements and ischemic conditioning; results posted in December 2020.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Chronic Clinical Effect of Acetazolamide [Phase 2, Phase 3]
Clinical trial update for chronic clinical effect of Acetazolamide in hypertension and pulmonary conditions, completed Phase 2 and Phase 3.
-
FDA approval · 2020-12-15FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for the fixed-dose combination of amlodipine besylate and atorvastatin calcium, manufactured by …
-
FDA approval · 2020-12-15FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for AVALIDE (irbesartan and hydrochlorothiazide) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2020-12-10FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Triamterene and Hydrochlorothiazide from BluePoint Laboratories.
-
FDA approval · 2020-12-10FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)
The FDA approved a supplemental ANDA for Triamterene and Hydrochlorothiazide from Zydus Pharmaceuticals (USA) Inc., enabling the generic pro…
-
CLINICAL_TRIALS trial_result · 2020-12-04Clinical Trial Update: Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic [Phase 4]
Phase 4 trial update on treating obstructive sleep apnea–associated hypertension with an alpha-2 agonist or a diuretic; results posted.
-
FDA approval · 2020-12-02FDA Approved: METOLAZONE — Original Application (Alembic Pharmaceuticals Limited)
Alembic Pharmaceuticals Limited's original application for metolazone received FDA approval, enabling the generic version to be marketed in …
-
FDA approval · 2020-11-30FDA Approved: IRBESARTAN — Supplemental Application (AvKARE)
FDA approves AvKARE's supplemental application for IRBESARTAN, enabling continued marketing of the generic irbesartan product.
-
CLINICAL_TRIALS trial_result · 2020-11-30Clinical Trial Update: A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia [Phase 3]
Phase 3 trial comparing co-administered HGP0608, HGP0904 and HCP1306 versus HCP1701 in hypertension and dyslipidemia has completed.
-
FDA approval · 2020-11-27FDA Approved: CHLORTHALIDONE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s original application for a generic chlorthalidone product.
-
FDA approval · 2020-11-25FDA Approved: GUANFACINE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved Slate Run Pharmaceuticals’ guanfacine as a generic product via an Original Application (ANDA213428).
-
FDA approval · 2020-11-25FDA Approved: ATENOLOL AND CHLORTHALIDONE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approves a generic fixed-dose combination of atenolol and chlorthalidone for the treatment of hypertension.
-
FDA approval · 2020-11-25FDA Approved: METOPROLOL SUCCINATE — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories, LLC's metoprolol succinate extended-release tablets as an original application (generic).
-
FDA approval · 2020-11-18FDA Approved: NIFEDIPINE — Original Application (Elite Pharmaceutical Solution, Inc.)
FDA approved the Original Application for nifedipine from Elite Pharmaceutical Solution, Inc., approving the generic nifedipine product.